Leaflet FLAMMACERIUM 10mg / g+22mg / g cream


Indicated for: angina pectoris

Route of administration: cutaneous

Substance: silver sulfadiazine + cerium nitrate (antihypertensives)

ATC: D06BA51 (Dermatologicals | Chemotherapeutics for topical use | Sulfonamides)

The combination of silver sulfadiazine and cerium nitrate is used for the treatment of burns and other skin injuries. Silver sulfadiazine has antimicrobial properties, while cerium nitrate helps reduce inflammation and promote healing.

The medication is applied topically as a cream, as directed by a doctor, usually once or twice daily. It is important for patients to follow the usage instructions to prevent infections.

Patients should be aware of potential side effects, such as local irritation, a burning sensation, or allergic reactions. It is important to inform the doctor of any unusual symptoms.

Common side effects include local irritation and a burning sensation. In rare cases, severe reactions such as allergic reactions or electrolyte imbalances may occur. Patients should be informed of these risks before use.

General data about FLAMMACERIUM 10mg / g+22mg / g

  • Substance: silver sulfadiazine + cerium nitrate
  • Date of last drug list: 01-04-2023
  • Commercial code: W57261001
  • Concentration: 10mg / g+22mg / g
  • Pharmaceutical form: cream
  • Quantity: 1
  • Product type: generic
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

  • Manufacturer: RECIPHARM PARETS - SPANIA
  • Holder: CN UNIFARM S.A. - ROMANIA
  • Number: 444/2019/01
  • Shelf life: 3 years